MARKET

LMNX

LMNX

Luminex
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.51
-0.58
-2.41%
Opening 15:10 12/04 EST
OPEN
24.06
PREV CLOSE
24.09
HIGH
24.40
LOW
23.37
VOLUME
277.48K
TURNOVER
--
52 WEEK HIGH
41.69
52 WEEK LOW
20.29
MARKET CAP
1.09B
P/E (TTM)
95.72
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Luminex Corp Director Eck Buys 4,487 Shares @Avg Price of $22.40/Share
-Form 4
Benzinga · 4d ago
Luminex Corp Shares Down 30.9% Since SmarTrend's Sell Call (LMNX)
SmarTrend identified a Downtrend for Luminex Corp (NASDAQ:LMNX) on August 7th, 2020 at $32.84. In approximately 4 months, Luminex Corp has returned 30.94% as of today's recent price of $22.68.
Comtex SmarTrend(R) · 11/25 05:35
Global Influenza Diagnostics Market (2020 to 2026) - by Test Type, End-user, and Geography
, /PRNewswire/ -- The report has been added to offering.
PR Newswire - PRF · 11/20 19:15
Worldwide Industry for Proteomics to 2025 - Key Drivers and Challenges
, /PRNewswire/ -- The report has been added to offering.
PR Newswire - PRF · 11/20 16:30
FDA authorizes first at-home rapid COVID-19 test
The FDA has issued an emergency use authorization ((EUA)) to the single-use COVID-19 diagnostic test kit from Lucira Health, a California manufacturer.The Lucira COVID-19 All-In-One at home test kit provides rapid results. To date,
Seekingalpha · 11/18 05:20
Luminex Corp Down 32.1% Since SmarTrend Downtrend Call (LMNX)
SmarTrend identified a Downtrend for Luminex Corp (NASDAQ:LMNX) on August 7th, 2020 at $32.84. In approximately 3 months, Luminex Corp has returned 32.10% as of today's recent price of $22.30.
Comtex SmarTrend(R) · 11/16 18:33
Global Ceramic Microspheres Market 2020-2027 - Volatile Cost of Raw Material is Hampering Market Growth
, /PRNewswire/ -- The report has been added to offering.
PR Newswire - PRF · 11/16 12:45
Musk questions accuracy of rapid coronavirus antigen tests
Testing, testing... One, two. Three, four."Something extremely bogus is going on. Was tested for covid four times today. Two tests came back negative, two came back positive. Same machine, same
Seekingalpha · 11/13 08:12
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LMNX. Analyze the recent business situations of Luminex through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LMNX stock price target is 37.50 with a high estimate of 48.00 and a low estimate of 22.00.
EPS
Institutional Holdings
Institutions: 312
Institutional Holdings: 45.54M
% Owned: 97.89%
Shares Outstanding: 46.53M
TypeInstitutionsShares
Increased
76
3.05M
New
73
273.04K
Decreased
63
4.12M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.83%
Healthcare Equipment & Supplies
+1.08%
Key Executives
Chairman/Director
G. Walter Loewenbaum
President/Chief Executive Officer/Director
Nachum Shamir
Chief Financial Officer/Senior Vice President - Finance/Treasurer
Harriss Currie
Senior Vice President/General Counsel/Secretary
Richard Rew
Senior Vice President
Todd Bennett
Senior Vice President
Chuck Collins
Senior Vice President
Nancy Fairchild
Senior Vice President
Tadd Lazarus
Senior Vice President
Randall Myers
Senior Vice President
Eric Shapiro
Lead Director/Independent Director
Edward Ogunro
Independent Director
Stephen Eck
Independent Director
Thomas Erickson
Independent Director
Jimmy Kever
Independent Director
Dijuana Lewis
Independent Director
Kevin McNamara
Independent Director
Kenneth Samet
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
09/10/2020
Dividend USD 0.09
09/23/2020
05/21/2020
Dividend USD 0.09
06/17/2020
02/13/2020
Dividend USD 0.09
03/18/2020
12/05/2019
Dividend USD 0.09
12/18/2019
07/29/2019
Dividend USD 0.09
09/25/2019
05/16/2019
Dividend USD 0.06
06/19/2019
02/07/2019
Dividend USD 0.06
03/20/2019
12/06/2018
Dividend USD 0.06
12/19/2018
09/06/2018
Dividend USD 0.06
09/20/2018
05/17/2018
Dividend USD 0.06
06/21/2018
01/23/2018
Dividend USD 0.06
03/22/2018
12/07/2017
Dividend USD 0.06
12/21/2017
09/07/2017
Dividend USD 0.06
09/21/2017
05/18/2017
Dividend USD 0.06
06/21/2017
02/20/2017
Dividend USD 0.06
03/22/2017
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About LMNX
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Luminex Corporation stock information, including NASDAQ:LMNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LMNX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LMNX stock methods without spending real money on the virtual paper trading platform.